Jakob Peter Cramer, a medical doctor with specializations in internal medicine, tropical medicine, travel medicine, and infectious diseases, joined CEPI (the Coalition for Epidemic Preparedness Innovations) as Head of Clinical Development in June 2019.
Before joining CEPI, he held the position of Head of the Section Tropical Medicine at the University Medical Center Hamburg-Eppendorf as well as the Clinical Research Unit at the Bernhard Nocht Institute for Tropical Medicine (BNITM) in Hamburg, Germany, where he founded the clinical trials unit and conducted Phase 1-2-3 vaccine trials against various infectious diseases (including influenza, rabies, Japanese encephalitis, meningococcal diseases, travellers’ diarrhoea).
During his 14 years in the academic environment, he engaged in epidemiological and investigator-initiated clinical research in Africa. From 2014 to 2019, Jakob held the position of Medical Director, Clinical Development, Vaccine Business Unit, Takeda Pharmaceuticals International AG, Zurich, Switzerland where he was actively involved in Takeda’s norovirus and dengue as well as the BMGF-funded polio vaccine development programs.
He is a lecturer at the Faculty of Medicine, University Medical Center Hamburg-Eppendorf, Germany, as well as the University of Siena MSc Course in Vaccinology, Italy, and a member of a series of infectious diseases societies.
